GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Interest Expense

PEPTONIC medical AB (XSAT:PMED) Interest Expense : kr-1.86 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PEPTONIC medical AB's interest expense for the three months ended in Sep. 2024 was kr -0.65 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was kr-1.86 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PEPTONIC medical AB's Operating Income for the three months ended in Sep. 2024 was kr -10.49 Mil. PEPTONIC medical AB's Interest Expense for the three months ended in Sep. 2024 was kr -0.65 Mil. PEPTONIC medical AB did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


PEPTONIC medical AB Interest Expense Historical Data

The historical data trend for PEPTONIC medical AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Interest Expense Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.63 -0.28 -0.07 -5.56 -2.32

PEPTONIC medical AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.46 -0.26 -0.50 -0.65

PEPTONIC medical AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PEPTONIC medical AB  (XSAT:PMED) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PEPTONIC medical AB's Interest Expense for the three months ended in Sep. 2024 was kr-0.65 Mil. Its Operating Income for the three months ended in Sep. 2024 was kr-10.49 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was kr0.00 Mil.

PEPTONIC medical AB's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

PEPTONIC medical AB did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


PEPTONIC medical AB Business Description

Traded in Other Exchanges
N/A
Address
Gustavslundsvagen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB Headlines

No Headlines